Intrust Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Intrust Bank's MRNA Position: Q4 2022 in Review
Intrust Bank sold out of Moderna (MRNA) in Q4 2022, closing a stake of 1,837 shares — an estimated $217K sold.
Intrust Bank first reported a position in MRNA in Q4 2021 and held it in 4 quarters. The position peaked at $353K in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.
- Intrust Bank reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
- Intrust Bank sold 1,837 Moderna shares in Q4 2022, an estimated $217K.
- Intrust Bank first reported a position in Moderna in Q4 2021 and held it in 4 quarters.
- Intrust Bank's Moderna position peaked at $353K in Q4 2021.
- 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.
Based on Intrust Bank's 13F filing for Q4 2022, filed 10 Feb 2023.